Drugs / Measles vaccine
Measles vaccine
Trials 14
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial · 1 met primary | ||||||
| Phase 3 | NCT00249769 | Nov 2005 → May 2006 | Japanese encephalitis | PATH | Completed | Met primary |
| Phase 411 trials · 1 missed | ||||||
| Phase 4 | NCT04899765 | May 2021 → Dec 2025 overdue | measles | Bandim Health Project | Recruiting | No outcome recorded |
| Phase 4 | NCT04220671 | Jan 2020 → Dec 2026 expected | measles | Bandim Health Project | Enrolling by invitation | No outcome recorded |
| Phase 4 | NCT03330171 | Apr 2017 → Feb 2019 | chickenpox, hepatitis A virus infection, measles | University of Witwatersrand, South Africa | Unknown | No outcome recorded |
| Phase 4 | NCT03460002 | Nov 2016 → Oct 2021 | measles | Bandim Health Project | Completed | No outcome recorded |
| Phase 4 | NCT02286895 | Oct 2014 → Mar 2015 | Rotavirus infection | PATH | Completed | No outcome recorded |
| Phase 4 | NCT01668745 | May 2013 → Dec 2015 | measles | Bandim Health Project | Completed | No outcome recorded |
| Phase 4 | NCT01644721 | Jul 2012 → Jun 2016 | measles | Bandim Health Project | Completed | No outcome recorded |
| Phase 4 | NCT01486355 | Aug 2011 → Jul 2016 | measles | Bandim Health Project | Unknown | Missed primary |
| Phase 4 | NCT00168545 | Jan 2006 → Jan 2007 | diphtheria, measles, pertussis, tetanus | Bandim Health Project | Completed | No outcome recorded |
| Phase 4 | NCT00168571 | Mar 2002 → Jan 2007 | measles | Bandim Health Project | Completed | No outcome recorded |
| Phase 4 | NCT00168662 | Mar 1995 → Jan 2006 | measles | Bandim Health Project | Completed | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT03170765 | Mar 2017 → May 2018 | measles | Post Graduate Institute of Medical Education and Research, Chandigarh | Unknown | No outcome recorded |
| — | NCT02943681 | Oct 2016 → May 2020 | — | Bandim Health Project | Completed | No outcome recorded |
| Comparator or background therapy4 trials | ||||||
| Phase 3 | NCT05794230 Background | Mar 2023 → Nov 2025 | meningococcal infection | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
| Phase 3 | NCT01345240 Background | Nov 2011 → Jan 2013 | malaria | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 4 | NCT01306006 Comparator | Feb 2011 → Dec 2017 | — | Bandim Health Project | Completed | No outcome recorded |
| — | NCT02710045 Comparator | Nov 2007 → Mar 2010 | — | Medical Research Council Unit, The Gambia | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 19 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Measles vaccine | “Children born from September 1994 to January 1996 were randomized into two groups receiving either two doses of measles vaccine at 6 and 9 months or one dose of inactivated...” PMID 10342702 ↗ Apr 1999 |
| Known as | CAM-70 | “HIV-unexposed (HU) (n = 212) and HIV-exposed, uninfected (HEU) (n = 71) children received measles vaccination (CAM-70) at 6 and 12 months of age.” PMID 31282539 ↗ Sep 2019 |
| Known as | Measles vaccine (MeasBio) 0.5 mL | “Measles vaccine (MeasBio) 0.5 mL” NCT03330171 ↗ |
| Modality | Vaccine | “Measles vaccine” NCT00168545 ↗ |
| Route | Intramuscular | “The measles and yellow fever vaccines were administered IM in the deltoid” NCT01345240 ↗ |